Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Tracheostomy is worldwide performed in Intensive Care Unit (ICU). According to the current literature, indication for percutaneous tracheostomy (PDT) in ICU are: difficult prolonged weaning, prolonged mechanical ventilation, loss of airway reflex, copious secretions, upper airway obstruction. Many studies have focused on the comparison between different PDT techniques and complication. The aim of our study is to evaluate the procedural features, complications, ICU mortality, quality of life, post-discharge mortality of patients undergoing different PDT techniques performed in ICU.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| critical ill patients | The investigator will enroll all the critical ill patients undergoing percutaneous tracheostomy performed in ICU |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Percutaneous tracheostomy | Procedure | Percutaneous tracheostomies will be performed with the kit commercially available in the current clinical practice. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Safety of percutaneous tracheostomy | at the beginning and at the end of the procedure |
| Measure | Description | Time Frame |
|---|---|---|
| Early complications | Early complications are:multiple intubation attempts (more than 1), accidental extubation, paratracheal insertion, injuries to blood vessels in the neck, oesophageal injury, accidental decannulation, malposition of the tracheostomy tube, tracheal cuff puncture, multiple punctures (more than 1), surgical conversion and percutaneous tracheostomy failure, minor bleeding (compressible), major bleeding (incompressible), pneumothorax |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Criticall ill patients requiring percutaneous tracheostomy in intensive care unit
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Paolo Pelosi, professor | Contact | +39 010 5553136 | ppelosi@hotmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Paolo Pelosi | Universita degli Studi di Genova | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Genoa | Recruiting | Genoa | Italy | 16132 | Italy |
Not provided
| ID | Term |
|---|---|
| D009422 | Nervous System Diseases |
| D006333 | Heart Failure |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| in the first 24 hours from the end of the procedure |
| Late complications | Late complications are: minor bleeding (compressible), major bleeding (incompressible) tracheostomy puncture site infection, subglottic stenosis, fracture of a tracheal cartilage, granuloma. | from the 2nd day ofter the procedure until the ICU discharge (expected average of 2 weeks) |
| Quality of life | The investigator will use the EURO-QOL | at 3, 6 and 12 months after tracheostomy |
| Evaluation of organ function | The investigator will perform a flexible fiberoptic laryngoscopy. | At 3, 6 , and 12 months after tracheostomy |
| Quality of voice | the investigator will use a KAY elemetrics analyzer. | At 3,6, 12 months after tracheostomy |
| Mortality | at 3, 6 and 12 months from tracheostomy |